| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.3M | +23.8% |
| SG&A Expense | $6.1M | -7.8% |
| Net Income | -$8.7M | +7.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.4M | -16.1% |
| Current Assets | $11.3M | -15.6% |
| Total Assets | $12.2M | -15.8% |
| Current Liabilities | $3.6M | +1.5% |
| Total Liabilities | $6.5M | -7.7% |
| Stockholders' Equity | $5.7M | -23.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.9M | +7.3% |
| Investing Cash Flow | $2.2M | +121.6% |
| Financing Cash Flow | $5.2M | -62.8% |